(Q31866812)

4 July 2017

Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial (English)

1 reference

4 July 2017

phase II clinical trial

0 references

1 reference

1 reference

1 reference

4

Rübben H

1 reference

4 July 2017

Otto T

1

1 reference

4 July 2017

Krege S

series ordinal

2

1 reference

4 July 2017

Suhr J

series ordinal

3

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

57

1 reference

4 July 2017

55-59

1 reference

4 July 2017

1

1 reference

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Initial chemotherapy for stage II testicular non-seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Control of malignant ascites with spironolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced B

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Outcome after limited posterior surgery for thoracic and lumbar spine metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Treatment of spinal metastases from kidney cancer by presurgical embolization and resection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Local control after surgical treatment of spinal metastatic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

The role of surgical excision in the management of relapsed Wilms' tumor patients with pulmonary metastases: A report from the National Wilms' Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Extended resection for locally advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900867-0

7 January 2021

10.1016/S0090-4295(00)00867-0

Identifiers

DOI

1 reference

4 July 2017

1 reference